These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22892062)

  • 41. Oral and oropharyngeal cancer in the West of Scotland-long-term outcome data of a prospective audit 1999-2001.
    McMahon JD; Robertson GA; Liew C; McManners J; Mackenzie FR; Hislop WS; Morley SE; Devine J; Carton AT; Harvey S; Hunter K; Robertson AG
    Br J Oral Maxillofac Surg; 2011 Mar; 49(2):92-8. PubMed ID: 20646803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Squamous cell carcinoma of the tongue and floor of the mouth: analysis of survival rate and independent prognostic factors in the Amazon region.
    Pontes FS; Carneiro JT; Fonseca FP; da Silva TS; Pontes HA; Pinto Ddos S
    J Craniofac Surg; 2011 May; 22(3):925-30. PubMed ID: 21558919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced gamma-catenin expression and poor survival in oral squamous cell carcinoma.
    Närkiö-Mäkelä M; Pukkila M; Lagerstedt E; Virtaniemi J; Pirinen R; Johansson R; Kosunen A; Lappalainen K; Hämäläinen K; Kosma VM
    Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1035-40. PubMed ID: 19841345
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does buccal cancer have worse prognosis than other oral cavity cancers?
    Camilon PR; Stokes WA; Fuller CW; Nguyen SA; Lentsch EJ
    Laryngoscope; 2014 Jun; 124(6):1386-91. PubMed ID: 24807684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy.
    Lavertu P; Adelstein DJ; Myles J; Secic M
    Laryngoscope; 2001 Nov; 111(11 Pt 1):1878-92. PubMed ID: 11801963
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of alpha-dystroglycan correlates with tumour grade and predicts survival in oral squamous cell carcinoma.
    Sgambato A; Caredda E; Leocata P; Rossi G; Boninsegna A; Vitale A; Grandi T; Cittadini A; Migaldi M
    Pathology; 2010 Apr; 42(3):248-54. PubMed ID: 20350218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prognostic implications of the surgical margin in oral squamous cell carcinoma.
    Sutton DN; Brown JS; Rogers SN; Vaughan ED; Woolgar JA
    Int J Oral Maxillofac Surg; 2003 Feb; 32(1):30-4. PubMed ID: 12653229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The number of pathologically positive lymph nodes and pathological tumor depth predicts prognosis in patients with poorly differentiated squamous cell carcinoma of the oral cavity.
    Kang CJ; Lin CY; Wang HM; Fan KH; Ng SH; Lee LY; Chen IH; Huang SF; Liao CT; Yen TC
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e223-30. PubMed ID: 21640500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
    Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
    J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral squamous cell carcinoma: clinicopathological features in patients with and without recurrence.
    Camisasca DR; Silami MA; Honorato J; Dias FL; de Faria PA; Lourenço Sde Q
    ORL J Otorhinolaryngol Relat Spec; 2011; 73(3):170-6. PubMed ID: 21625192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Catenin expression in T1/2 carcinomas of the floor of the mouth.
    Fillies T; Buerger H; Gaertner C; August C; Brandt B; Joos U; Werkmeister R
    Int J Oral Maxillofac Surg; 2005 Dec; 34(8):907-11. PubMed ID: 15916880
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of nodal ratio on survival in squamous cell carcinoma of the oral cavity.
    Shrime MG; Ma C; Gullane PJ; Gilbert RW; Irish JC; Brown DH; Goldstein DP
    Head Neck; 2009 Sep; 31(9):1129-36. PubMed ID: 19340867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of a high-risk group among patients with oral cavity squamous cell carcinoma and pT1-2N0 disease.
    Liao CT; Lin CY; Fan KH; Wang HM; Ng SH; Lee LY; Hsueh C; Chen IH; Huang SF; Kang CJ; Yen TC
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):284-90. PubMed ID: 21075550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
    Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
    Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tongue cancer: Is there a difference in survival compared with other subsites in the oral cavity?
    Bell RB; Kademani D; Homer L; Dierks EJ; Potter BE
    J Oral Maxillofac Surg; 2007 Feb; 65(2):229-36. PubMed ID: 17236926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum decoy receptor 3 level: a predictive marker for nodal metastasis and survival among oral cavity cancer patients.
    Tu HF; Liu CJ; Liu SY; Chen YP; Yu EH; Lin SC; Chang KW
    Head Neck; 2011 Mar; 33(3):396-402. PubMed ID: 20645287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM Stage I and II squamous cell carcinoma of the oral cavity.
    Myo K; Uzawa N; Miyamoto R; Sonoda I; Yuki Y; Amagasa T
    Cancer; 2005 Dec; 104(12):2709-16. PubMed ID: 16265665
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of activated Akt expression in oral squamous cell carcinoma.
    Lim J; Kim JH; Paeng JY; Kim MJ; Hong SD; Lee JI; Hong SP
    J Clin Pathol; 2005 Nov; 58(11):1199-205. PubMed ID: 16254112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcome analysis of patients with pN2 oral cavity cancer.
    Liao CT; Huang SF; Chen IH; Kang CJ; Lin CY; Fan KH; Wang HM; Ng SH; Hsueh C; Lee LY; Tsao CK; Yen TC
    Ann Surg Oncol; 2010 Apr; 17(4):1118-26. PubMed ID: 20135357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MIB 1 immunostaining in stage I squamous cervical carcinoma: relationship with natural killer cell activity.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; de Nictolis M; Muzzioli M; Fabris N; Romanini C; Biagini G
    Gynecol Oncol; 1995 Jul; 58(1):28-33. PubMed ID: 7789886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.